Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Interest Expenses (2016 - 2019)

Historic Interest Expenses for Anaptysbio (ANAB) over the last 4 years, with Q4 2019 value amounting to $200000.0.

  • Anaptysbio's Interest Expenses fell 4520.55% to $200000.0 in Q4 2019 from the same period last year, while for Sep 2020 it was $200000.0, marking a year-over-year decrease of 8341.63%. This contributed to the annual value of $1.0 million for FY2019, which is 3698.55% down from last year.
  • Anaptysbio's Interest Expenses amounted to $200000.0 in Q4 2019, which was down 4520.55% from $240000.0 recorded in Q3 2019.
  • Anaptysbio's 5-year Interest Expenses high stood at $456000.0 for Q4 2017, and its period low was $111000.0 during Q4 2016.
  • Moreover, its 4-year median value for Interest Expenses was $342500.0 (2018), whereas its average is $307875.0.
  • As far as peak fluctuations go, Anaptysbio's Interest Expenses skyrocketed by 31081.08% in 2017, and later crashed by 4520.55% in 2019.
  • Quarter analysis of 4 years shows Anaptysbio's Interest Expenses stood at $111000.0 in 2016, then soared by 310.81% to $456000.0 in 2017, then decreased by 19.96% to $365000.0 in 2018, then crashed by 45.21% to $200000.0 in 2019.
  • Its Interest Expenses stands at $200000.0 for Q4 2019, versus $240000.0 for Q3 2019 and $281000.0 for Q2 2019.